PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection
Authors:
- Yong Han PaikYPYong Han Paik
- Sang Hoon AhnSASang Hoon Ahn
- Young Jun YounYYYoung Jun Youn
- Jong Won ChoiJCJong Won Choi
- Ja Kyung KimJKJa Kyung Kim
- Kwan Sik LeeKLKwan Sik Lee
- Chae Yoon ChonCCChae Yoon Chon
- Kwang Hyub HanKHKwang Hyub Han
- 1 December 2007
- journal article
- Published by S. Karger AG in Oncology
- Vol. 72 (Suppl. 1) , 52-57
Abstract
Objectives: The aim of this study is to assess the usefulness of prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) in monitoring of recurrent hepatocellular carcinoma (HCC) after curative resection. Methods: From April 2001 to March 2004, a total of 245 patients with histologically proven HCC and 267 non-HCC patients were recruited. Serial follow-up measurements of both alpha-fetoprotein (AFP) and PIVKA-II were performed in 27 patients who had recurrent HCC after resection. Results: In the initial HCC diagnosis, the sensitivity of AFP and PIVKA-II was 48.6% (119/245) and 75.1% (184/245), respectively, at the cutoff of 20 ng/ml for AFP and 40 mAU/ml for PIVKA-II (p < 0.01). The specificity was 81.3% (217/267) and 94.8% (253/267), respectively. When AFP and PIVKA-II were combined, the sensitivity and specificity was 83.3% (204/245) and 77.2% (206/267), respectively. In 27 patients developing recurrent HCC after curative surgical resection, the sensitivity of AFP and PIVKA-II was 40.7% (11/27) and 74.1% (20/27), respectively. Several fluctuating patterns of AFP and PIVKA-II were observed from initial diagnosis to recurrence. Conclusion: Our data suggest that PIVKA-II is a useful tumor marker for HCC, complementary to AFP. Serial measurements of both markers after resection might be helpful for early diagnosis of tumor recurrence.Keywords
This publication has 20 references indexed in Scilit:
- Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP, DCP, and AFP-L31Cancer Biomarkers, 2007
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Predictors and patterns of recurrence after resection of hepatocellular carcinomaJournal of the American College of Surgeons, 2003
- Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoproteinBritish Journal of Cancer, 2003
- Des–Gamma Carboxyprothrombin Can Differentiate Hepatocellular Carcinoma From Nonmalignant Chronic Liver Disease in American PatientsHepatology, 2003
- Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinomaCancer, 1996
- Clinical usefulness of des-?-carboxy prothrombin assay in early diagnosis of hepatocellular carcinomaDigestive Diseases and Sciences, 1991
- Early recognition of hepatocellular carcinomaHepatology, 1986
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984
- The Role of Biologic Tumor Markers in Testicular CancerCancer, 1980